Appen Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APXYY research report →
Price Chart
About the company
Appen Limited operates as an AI lifecycle company that provides data sourcing, data annotation, and model evaluation solutions in Australia, the United States, and internationally. It operates through the Appen Global and Appen China segments. The company offers CrowdGen, the interface for its global crowd workforce; Mercury, the backend system used to design projects, manage the crowd workforce, and automate operational workflows; AI Data Platform (ADAP), which enables internal teams and external customers to design, manage, and execute human annotation and evaluation tasks; MatrixGo, the core platform supporting data collection and annotation services; Elite AI, the expert crowdsourcing platform enables expert recruitment, task publishing, and campaign referral expansion for user acquisition; MediGo, a medical LLM and image annotation; RoboGo, an embodied intelligence; and Appen Task, a mobile data collection application.
- CEO
- Ryan Kolln
- IPO
- 2021
- Employees
- 1,185
- HQ
- Sydney, NSW, AU
Get TickerSpark's AI analysis on APXYY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $196.10M
- P/E
- -27.77
- PEG
- -0.43
- P/S
- 0.79
- P/B
- 2.09
- EV/EBITDA
- 8.76
- Div Yield
- 0.00%
- Gross Margin
- 8.32%
- Op Margin
- -2.41%
- Net Margin
- -2.81%
- ROE
- -7.45%
- ROIC
- -5.87%
Latest fiscal year · YoY change
- Revenue
- $230.94M-1.4%
- Gross Profit
- $7.50M+0.4%
- Op Income
- $-21,062,371
- Net Income
- $-21,833,935-76.3%
- EPS
- $-0.04-46.7%
- OCF Growth
- +3561.3%
- FCF Growth
- +240.3%
- 52W High
- $0.58
- 52W Low
- $0.18
- 50D MA
- $0.37
- 200D MA
- $0.42
- Beta
- 1.84
- RSI (14)
- 58
- Avg Volume
- 1.38K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Appen delivered strong H1 FY '26 growth and a meaningful EBITDA improvement, driven by surging China revenue and better cost discipline, while maintaining FY '26 guidance.· August 26, 2026
- Group revenue rose 17% to $119.9 million, with underlying EBITDA before FX up $7.5 million to $5.3 million and margin at 4.5%.
- Appen China was the standout: revenue grew 80.4% to $76.2 million and exited June at an annualized run rate above $175 million.
- Appen Global remained under pressure at $43.7 million, down 26.9%, but management said traditional work has stabilized and new AI lab work is growing.
- Gross margin slipped slightly to 36.7%, mainly due to mix, while China margins improved on higher GenAI and pre-built data-set revenue.
- Management reiterated FY '26 guidance of $270 million to $300 million revenue and 5% to 10% underlying EBITDA before FX margin.
Appen reported H1 FY '26 revenue of $119.9 million, up 17.5% year over year, with Appen China revenue up 80.4% to $76.2 million and Appen Global revenue down 26.9% to $43.7 million. Gross margin was 36.7%, down 30 basis points year over year. Underlying EBITDA before FX was $5.3 million, an improvement of $7.5 million versus H1 FY '25, and EBITDA margin was 4.5%. Cash at 30 June was $44.7 million, equivalent to AUD 64.8 million. For FY '26, management reaffirmed group revenue guidance of $270 million to $300 million and underlying EBITDA before FX margin guidance of 5% to 10%.
Ryan Kolln emphasized that Appen is benefiting from demand for scarce, real-world data used in AI model development, and framed the business as serving leading foundation model builders across the U.S. and China. He highlighted a broader product set, stronger relationships with AI labs, and a focus on technology-led efficiencies, saying the company has identified about $12 million in incremental operational efficiencies without harming growth capability. His tone was confident and constructive, especially on China and on the improving pipeline in Appen Global.
Justin Miles walked through the P&L and cash flow, noting revenue of $119.9 million, gross margin of 36.7%, and underlying EBITDA before FX of $5.3 million. He said Appen Global employee expenses fell 19% to $14.4 million and other expenses fell 29% to $8.1 million, while cash used in operations was $2.7 million and investing cash outflow was $1.9 million higher due to product development and new facilities in China. He also said the company has enough cash and working capital, with $44.7 million in cash at period end and no need for additional funding.
Analysts focused on whether the EBITDA improvement is sustainable, how much cash runway remains, and what revenue base is needed to stay profitable in H2. Management said the improvement is driven by both China margin expansion and Appen Global cost-outs, and that H2 profitability should not require a material uplift from Q2 levels. They also said the $12 million cost-efficiency program will begin flowing through in the second half, with the full benefit starting in Q2 next year, and that current cash resources should be sufficient to reach self-sustainability.
The positive case from this call is that Appen is showing real operating leverage, with China scaling strongly and China margins improving as GenAI and pre-built data sets grow. Management also sounded encouraged by new work with leading AI labs, stabilization in traditional Global work, and a faster sales cycle for newer opportunities.
The main risks are that Appen Global revenue is still declining, new areas have not yet fully offset traditional work loss, and a meaningful part of the cost-out benefit is delayed until later periods. Management also acknowledged customer concentration, shifting project timing, and that some large projects from prior periods have not clearly resumed yet, leaving second-half execution important.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 50.3%
- Shares Outstanding
- 538.04M
- Float Shares
- 270.58M
Our APXYY coverage
Recent articles, reports, and earnings notes.
Want a deeper read on APXYY?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Appen Limited (APXYY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 27
Appen Limited (APXYY) Shareholder/Analyst Call Transcript
seekingalpha.com · May 22
Appen Limited (APXYY) Q4 2025 Earnings Call Transcript
seekingalpha.com · Feb 24
Appen Limited (APPEF) Q2 2025 Earnings Call Transcript
seekingalpha.com · Aug 28
Appen Limited (APPEF) Q4 2024 Earnings Call Transcript
seekingalpha.com · Feb 26
Appen Limited (APPEF) Q2 2024 Earnings Call Transcript
seekingalpha.com · Aug 29
3 AI Stocks That AI Bots Think You Should Sell
investorplace.com · Jun 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
